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Abstract
Introduction: Ethylene glycol poisoning may pose diagnostic difficulties if the history of ingestion is not volunteered, 
or if the presentation is delayed. This is because the biochemical features of high anion-gap metabolic acidosis and an 
osmolar gap resolve within 24 to 72 hours as the ethylene glycol is metabolized to toxic metabolites. This case 
illustrates the less well-known clinical features of delayed ethylene glycol poisoning, including multiple cranial and 
peripheral neuropathies, and the clinical findings which may point towards this diagnosis in the absence of a history of 
ingestion.
Case presentation: A 53-year-old Afro-Caribbean man presented with vomiting, abdominal pain and oliguria, and was 
found to have acute renal failure requiring emergency hemofiltration, and raised inflammatory markers. Computed 
tomography imaging of the abdomen revealed the appearance of bilateral pyelonephritis, however he failed to 
improve with broad-spectrum antibiotics, and subsequently developed multiple cranial neuropathies and increasing 
obtundation, necessitating intubation and ventilation. Computed tomography of the brain showed no focal lesions, 
and a lumbar puncture revealed a raised cerebrospinal fluid opening pressure and cyto-albuminological dissociation. 
Nerve conduction studies revealed a sensorimotor radiculoneuropathy mimicking a Guillain-Barre type lesion with an 
atypical distribution. It was only about two weeks after presentation that the history of ethylene glycol ingestion one 
week before presentation was confirmed. He had a slow recovery on the intensive care unit, requiring renal 
replacement therapy for eight weeks, and complicated by acute respiratory distress syndrome, neuropathic pain and a 
slow neurological recovery requiring prolonged rehabilitation.
Conclusions: Although neuropathy as a result of ethylene glycol poisoning has been described in a few case reports, 
all of these were in the context of a known history of ingestion. As the diagnosis may well be obscured if the history of 
ingestion is not elucidated, it is important to be aware of this possibility especially if presentation is delayed.
Introduction
Ethylene glycol (EG) is a common constituent of anti-
freeze, coolants and other solvents and is responsible for
both inadvertent and intentional poisoning with a
reported incidence of exposure in the USA of almost
5000 episodes annually [1]. The diagnosis of EG poison-
ing is relatively obvious in an individual presenting with a
history of ingestion, and a clinical presentation consistent
with poisoning, associated with a high anion-gap meta-
bolic acidosis and elevated osmolar gap. EG is metabo-
lized to oxalic acid within 24 to 72 hours and the
formation of calcium oxalate monohydrate crystals in the
urine, although not specific to the condition, may assist in
its elucidation [2].
Even more delayed presentation precludes biochemical
evidence of ingestion from the urinalysis, and without a
history of exposure, the diagnosis is dependent on anam-
nesis and a high index of suspicion. There have been pre-
vious case reports of neuropathy secondary to EG
ingestion, but usually the toxin ingestion is elucidated
before the symptoms become apparent, rather than the
symptom pattern assisting in the identification of the
toxin.
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A 53-year-old Afro-Caribbean man was admitted to
another institution with a two-day history of vomiting,
hiccups and abdominal pain. He was felt to have gastro-
enteritis, given intravenous fluids, paracetamol and cycl-
izine and discharged from the accident and emergency
department. Two days later he presented to his general
practitioner (GP) with continuing epigastric and lower
abdominal pain, vomiting, having not opened his bowels
or passed urine for four days.
He had a history of hypercholesterolemia, but was on
no regular medications aside from those prescribed two
days earlier. He smoked ten cigarettes a day, denied alco-
hol intake and had no recent travel history. On examina-
tion he was apyrexial, clinically dehydrated, with vital
signs of pulse rate of 108 per minute and blood pressure
of 145/82. Physical examination revealed a generally ten-
der but not peritonitic abdomen and an empty rectum,
but was otherwise unremarkable. A urethral catheter was
passed and a urine dipstick was strongly positive for
blood, protein and less so for glucose and leukocytes.
Laboratory studies revealed a sodium level of 131
mmol/L, potassium level of 6.7 mmol/L, urea of 45.2
mmol/L, and creatinine of 1885 micromol/L (21.3 mg/
dL). Of note were a raised C-reactive protein of 421, neu-
trophil count of 25.9 × 109/L and an erythrocyte sedi-
mentation rate of 100. Blood gases revealed a pH of 7.19,
a PO2 of 14.8 kPa, pCO2 of 5.18 kPa, HCO3 of 14.5 mmol/
L with a base deficit of -12.9 on 28% inspired oxygen, and
an anion gap of 28 mmol/l. An urgent renal ultrasound
showed normal sized kidneys with no hydronephrosis
and an empty bladder.
He was transferred urgently to the intensive care unit
for continuous veno-venous hemodiafiltration and
started on ciprofloxacin empirically in view of the history
of abdominal pain and raised inflammatory markers.
He was transferred the next day to the renal unit at our
centre. A computed tomography (CT) scan of his abdo-
men showed bilateral perinephric stranding suggestive of
pyelonephritis but was otherwise unremarkable (Figure
1). Investigations for underlying causes of the acute renal
failure including auto-antibodies, complements and pro-
tein electrophoresis were normal.
The patient remained dependent on intermittent
hemodialysis. He subsequently complained of back and
loin pain, and blurred vision, and was intermittently con-
fused and agitated. On day four of admission he reported
having drunk 'battery acid' by mistake one week before
his initial presentation, and his family reported a history
of cocaine use. At this time there was no focal neurology
elicited on examination, and no evidence of mucositis
consistent with battery acid ingestion.
On day five of admission he developed respiratory dis-
tress due to acute pulmonary edema and possible aspira-
tion pneumonia requiring emergency intubation,
ventilation and transfer to the intensive care unit (Figure
2).
Following a good response to antibiotics for aspiration
pneumonia, he was extubated within 24 hours, and
appeared alert and able to obey commands. Neurological
assessment revealed bilateral dilated pupils with sluggish
responses to light, and myoclonic jerks of his limbs. Sub-
sequently he became more obtunded and was reintubated
for a decreased level of consciousness and hypercapnia.
A CT scan of his brain showed no focal intra-cranial
lesion, and a lumbar puncture was performed which
showed an elevated opening pressure of 37 cmH20, mark-
edly raised cerebrospinal fluid (CSF) protein at 2785 mg/
L but normal CSF white cells 3 × 106/L and no organisms.
Figure 1 Computed tomography of abdomen on presentation.
Figure 2 Chest radiograph on day five.
Baldwin and Sran Journal of Medical Case Reports 2010, 4:220
http://www.jmedicalcasereports.com/content/4/1/220
Page 3 of 4He had a tracheostomy inserted and was subsequently
co-operative enough to comply with a neurological exam-
ination. This revealed bilateral palsies of cranial nerves
III, VI and VII, and slow tongue movements but normal
palatal movements. He also had distal lower limb weak-
ness with diminished reflexes and down-going plantars
and was beginning to complain of distal neuropathic
pains. Electromyography and nerve conduction studies
revealed a sensorimotor radiculoneuropathy with facial
nerve involvement, similar to that seen in Guillain-Barre
syndrome, with an atypical distribution.
Faced with a patient with acute renal failure and unex-
plained neurological disease, a review of the history of
toxin ingestion and literature search was performed. The
patient remained adamant that he had consumed battery
acid, but by this stage he was lucid enough to use his
mobile telephone to text his friend to bring in what was
by this stage strongly suspected to be anti-freeze. An
empty bottle of anti-freeze and coolant was brought in by
his friend and the patient confirmed that this was what he
had ingested. The product literature confirmed the pres-
ence of ethandiol or EG in concentrations of > 90%. As he
was anuric for several weeks from admission, it was not
possible to analyze a urine specimen for calcium oxalate
crystals once this diagnosis became apparent.
Our patient continued to have a rocky course on inten-
sive care complicated by acute respiratory distress syn-
drome (ARDS), presumed secondary to aspiration
pneumonia complicating bulbar palsy, and a slow respira-
tory wean. He required continuous veno-venous hemofil-
tration for eight weeks, and is currently independent of
dialysis but continues to have a severe degree of renal
impairment with an estimated glomerular filtration rate
(eGFR) of 13 mL/min. He is likely to require renal
replacement therapy in the near future. Neurological
recovery was also slow, but he was able to walk again
about ten weeks after admission, although rehabilitation
was also impaired by marked postural hypotension and
persisting neuropathic pain.
Discussion
This case illustrates the difficulties posed by delayed and
concealed EG poisoning. In this case, our patient did not
initially volunteer a history of toxin ingestion, and due to
the late presentation, initial features such as sedation and
inebriation had resolved. The raised anion gap at presen-
tation was presumed secondary to the renal failure and
given the delay in presentation and the time course of the
excretion of EG, this remains the most likely explanation.
Our patient's presenting symptoms of abdominal pain,
constipation and anuria, along with the investigations
revealing raised inflammatory markers, acute renal fail-
ure and an abdominal CT which suggested bilateral
pyelonephritis, pointed towards a diagnosis of intra-
abdominal sepsis leading to acute renal failure. However,
the lack of response to broad-spectrum antibiotics, the
history of toxin ingestion and the development of cranial
neuropathies pointed towards another diagnosis.
Differential diagnoses considered included a polyneu-
ropathy due to uremia, however this was less likely as the
neuropathy developed several days after dialysis was
commenced. Other differentials included diabetes melli-
tus, vasculitis, rheumatoid arthritis, systemic lupus ery-
thematosus, amyloidosis, sarcoidosis, multiple myeloma
or other light-chain deposition diseases, and HIV infec-
tion, which could also cause renal failure and neuropa-
thies. These differentials were effectively ruled out with
the negative autoantibody screen, normal serum electro-
phoresis and bone marrow biopsy, negative HIV test and
normal blood glucose level. Guillain-Barre syndrome was
a significant differential; however, once the history of
toxin ingestion was elucidated, this became less likely.
Symptoms and signs of EG poisoning are traditionally
divided into chronological stages [3]. Stage 1, occurring
within 12 hours, consists of central nervous system
(CNS) depression, and features of intoxication such as
slurred speech and confusion. Stage 2 occurs 12 to 24
hours after ingestion and is characterized by cardiovascu-
lar features such as tachycardia, hypertension and hyper-
ventilation due to the production of acid metabolites.
Stage 3 occurs after 48 hours and is characterized by
acute renal failure [4].
There have been reports in the literature regarding EG
and diethylene glycol poisoning causing delayed neuro-
logical deficits. However, this phenomenon is still not
well described. It may be that, with improvements in
medical care, more patients with severe overdoses, which
previously would have been fatal, are surviving and there-
fore displaying these delayed sequelae.
These usually present about one to two weeks after the
initial ingestion [4] with cranial neuropathies, including
bilateral facial palsy and ophthalmoplegia, as well as
peripheral sensorimotor neuropathies which can be
severe enough to cause complete paralysis [5]. Lumbar
puncture tends to show cytoalbuminological dissociation
[6,7], although there can be a CSF leukocytosis [8]. CT
brain tends to be normal but magnetic resonance imaging
may show abnormal enhancement of cranial nerve nuclei
[6,7]. Neurophysiology may show a primary axonal poly-
neuropathy [5,7], a primary demyelinating pathology [9],
or a polyradiculopathy [10,11]. There has been one other
case report that mentions the findings of bilateral peri-
nephric stranding on CT in the context of diethylene gly-
col poisoning [7]. The cases in the literature describe
both continued dependence on renal replacement, as well
as recovery from acute renal failure, which does not seem
to be related to the degree of neurological recovery.
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This case illustrates the diagnostic conundrum that a
delayed presentation of EG poisoning may pose. In these
situations, therapeutic interventions such as alcohol
dehydrogenase inhibition therapy are less of an issue as
the offending compound would have been metabolized
due to its short half-life. Supportive therapy in terms of
renal replacement therapy and ventilatory support for
severe neurological deficits are the mainstay of treatment.
These patients often have a prolonged course and require
extensive rehabilitation.
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